Total Payments
$853,913
2024 Payments
$23,612
Companies
35
Transactions
1,481
Medicare Patients
759
Medicare Billing
$88,093
Payment Breakdown by Category
Other$585,449 (68.6%)
Travel$123,941 (14.5%)
Consulting$117,353 (13.7%)
Food & Beverage$26,542 (3.1%)
Education$629.12 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $583,049 | 283 | 68.3% |
| Travel and Lodging | $123,941 | 433 | 14.5% |
| Consulting Fee | $117,353 | 52 | 13.7% |
| Food and Beverage | $26,542 | 689 | 3.1% |
| Honoraria | $2,400 | 1 | 0.3% |
| Education | $629.12 | 23 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $675,084 | 1,008 | $0 (2024) |
| Lilly USA, LLC | $78,672 | 114 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $34,911 | 36 | $0 (2024) |
| Amgen Inc. | $28,213 | 84 | $0 (2023) |
| UCB, Inc. | $25,802 | 70 | $0 (2023) |
| PFIZER INC. | $4,143 | 18 | $0 (2023) |
| GENZYME CORPORATION | $2,438 | 6 | $0 (2023) |
| Janssen Biotech, Inc. | $2,069 | 33 | $0 (2022) |
| GlaxoSmithKline, LLC. | $358.59 | 17 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $351.46 | 20 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,612 | 25 | ABBVIE INC. ($22,042) |
| 2023 | $209,090 | 265 | ABBVIE INC. ($153,298) |
| 2022 | $168,380 | 242 | ABBVIE INC. ($125,436) |
| 2021 | $95,798 | 179 | AbbVie Inc. ($67,759) |
| 2020 | $79,658 | 126 | AbbVie Inc. ($55,799) |
| 2019 | $144,407 | 349 | AbbVie, Inc. ($127,141) |
| 2018 | $91,383 | 197 | AbbVie, Inc. ($82,283) |
| 2017 | $41,586 | 98 | AbbVie, Inc. ($41,326) |
All Payment Transactions
1,481 individual payment records from CMS Open Payments — Page 1 of 60
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | RINVOQ (Biological), HUMIRA | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: IMMUNOLOGY | ||||||
| 05/16/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: IMMUNOLOGY | ||||||
| 05/01/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: IMMUNOLOGY | ||||||
| 02/23/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $292.84 | General |
| 02/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $41.27 | General |
| Category: Dermatology | ||||||
| 02/17/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $30.13 | General |
| Category: Dermatology | ||||||
| 02/17/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 02/08/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: IMMUNOLOGY | ||||||
| 02/02/2024 | Lilly USA, LLC | TALTZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,150.00 | General |
| Category: Immunology | ||||||
| 01/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/30/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/29/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: Immunology | ||||||
| 01/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $1,983.85 | General |
| Category: IMMUNOLOGY | ||||||
| 01/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $257.60 | General |
| Category: IMMUNOLOGY | ||||||
| 01/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $239.71 | General |
| Category: IMMUNOLOGY | ||||||
| 01/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: IMMUNOLOGY | ||||||
| 01/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $427.89 | General |
| Category: IMMUNOLOGY | ||||||
| 01/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $158.96 | General |
| Category: IMMUNOLOGY | ||||||
| 01/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $115.35 | General |
| Category: IMMUNOLOGY | ||||||
| 01/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 35 | 49 | $17,627 | $3,773 |
| 2021 | 12 | 369 | 1,179 | $83,966 | $54,163 |
| 2020 | 10 | 355 | 482 | $54,649 | $30,157 |
Total Patients
759
Total Services
1,710
Medicare Billing
$88,093
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 23 | 36 | $17,477 | $3,667 | 21.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 12 | 13 | $150.00 | $106.68 | 71.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 112 | 219 | $31,695 | $23,072 | 72.8% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 11 | 660 | $17,820 | $10,949 | 61.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 66 | 66 | $13,860 | $8,557 | 61.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 33 | 41 | $4,590 | $2,494 | 54.3% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 16 | 19 | $3,800 | $2,331 | 61.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 28 | $3,005 | $1,810 | 60.2% |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | Office | 2021 | 18 | 24 | $2,280 | $1,635 | 71.7% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 12 | 17 | $2,485 | $1,239 | 49.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $1,650 | $960.30 | 58.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 23 | 24 | $1,665 | $658.18 | 39.5% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 17 | 20 | $700.00 | $237.20 | 33.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 26 | 50 | $416.00 | $221.87 | 53.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 83 | 155 | $21,700 | $11,842 | 54.6% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 39 | 39 | $8,190 | $4,525 | 55.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 37 | 41 | $5,060 | $3,533 | 69.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 51 | 64 | $5,535 | $3,333 | 60.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 51 | 56 | $4,760 | $2,999 | 63.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 27 | 27 | $4,050 | $1,718 | 42.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 14 | 26 | $2,834 | $935.13 | 33.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 17 | 19 | $1,140 | $630.67 | 55.3% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 12 | 15 | $900.00 | $485.11 | 53.9% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2020 | 24 | 40 | $480.00 | $155.72 | 32.4% |
About Dr. Rachel Tate, DO
Dr. Rachel Tate, DO is a Internal Medicine healthcare provider based in Hollywood, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2009. The National Provider Identifier (NPI) number assigned to this provider is 1568694354.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rachel Tate, DO has received a total of $853,913 in payments from pharmaceutical and medical device companies, with $23,612 received in 2024. These payments were reported across 1,481 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($583,049).
As a Medicare-enrolled provider, Tate has provided services to 759 Medicare beneficiaries, totaling 1,710 services with total Medicare billing of $88,093. Data is available for 3 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location Hollywood, FL
- Active Since 08/13/2009
- Last Updated 12/03/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1568694354
Products in Payments
- RINVOQ (Biological) $305,795
- Humira (Biological) $132,468
- TALTZ (Drug) $59,836
- SKYRIZI (Biological) $58,193
- Rinvoq (Biological) $51,399
- RINVOQ (Drug) $42,493
- COSENTYX (Biological) $29,993
- Enbrel (Biological) $27,889
- HUMIRA (Biological) $13,652
- Cimzia (Drug) $11,845
- Bimzelx (Biological) $5,529
- XELJANZ (Drug) $2,639
- KEVZARA (Biological) $2,376
- SIMPONI ARIA (Biological) $1,837
- ABRILADA (Biological) $1,480
- COSENTYX (Drug) $701.13
- BENLYSTA (Biological) $358.59
- ORENCIA (Biological) $327.21
- TREMFYA (Drug) $236.29
- EVENITY (Biological) $228.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hollywood
Jeffrey Levy, Md Phd, MD PHD
Internal Medicine — Payments: $1.5M
Internal Medicine $1.5M
Steven Zeig, Md, MD
Internal Medicine — Payments: $85,147
Internal Medicine $85,147
Dr. Juan Rondon, Md, MD
Internal Medicine — Payments: $48,378
Internal Medicine $48,378
Dr. Ari Bennett, Md, MD
Internal Medicine — Payments: $20,880
Internal Medicine $20,880
Zael Vazquez, M.d, M.D
Internal Medicine — Payments: $16,966
Internal Medicine $16,966
Dr. Moises Issa, M.d, M.D
Internal Medicine — Payments: $14,241
Internal Medicine $14,241